KRAS and diffuse large B-cell lymphoma: In conclusion, this study explores a promising new target molecule related to the ER pathway that predicts the prognosis of DLBCL and analyzes that the STAT and KRAS pathways may be the potential growth regulation pathways of DLBCL.